✦ LIBER ✦

Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy

✍ Scribed by Jörg Beyer; Dorothea Kingreen; Manuela Krause; Jan Schleicher; Ingo Schwaner; Nimrod Schwella; Dieter Huhn; Wolfgang Siegert

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 99 KB
Volume: 79
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970101)79:1<161::aid-cncr23>3.0.co;2-1

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

The optimal treatment of patients with recurrent or refractory germ

📜 SIMILAR VOLUMES

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients

✍ Takao Shinozuka; Tsuyoshi Miyamoto; Toshinari Muramatsu; Takeshi Hirasawa; Masar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi

Hyperthermia for the treatment of patien

Hyperthermia for the treatment of patients with malignant germ cell tumors : A Phase I/II study in ten children and adolescents with recurrent or refractory tumors

✍ Rüdiger Wessalowski; Heidi Kruck; Hildegard Pape; Thomas Kahn; Reinhart Willers; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

waves in combination with platinum-based chemotherapy in ten children and 4 Institute of Statistics, Heinrich-Heine Univeradolescents with recurrent or refractory GCTs. sity, Du ¨sseldorf, Germany. ## RESULTS. Seven of ten patients with recurrent or refractory GCTs had objective responses. Of the